Health2 days ago
Jason Aryeh Exercises Stock Options, Gains $234,235 at Ligand
On December 9, 2025, significant insider activity at Ligand Pharmaceuticals (NASDAQ:LGND) was disclosed as Jason Aryeh, a director at the company, exercised stock options for a...